CSF and Plasma Pharmacokinetics of Eslicarbazepine Acetate and Oxcarbazepine in Healthy Volunteers

被引：0
|
作者：
Kharidia, Jahnavi
Nunes, Teresa
Versavel, Mark
Zummo, Jacqueline
Blum, David
Maier, Gary
Soares-da-Silva, Patricio
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A618 / A618
页数：1
相关论文
共 50 条
  • [41] The pharmacokinetics of starch acetate-diltiazem tablet formulations in healthy volunteers
    Korhonen, O
    Kanerva, H
    Vidgren, M
    Ketolainen, J
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 : S19 - S19
  • [42] Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers
    Antunes, Natalicia de Jesus
    Wichert-Ana, Lauro
    Coelho, Eduardo Barbosa
    Della Pasqua, Oscar
    Alexandre Junior, Veriano
    Takayanagui, Osvaldo Massaiti
    Tozatto, Eduardo
    Marques, Maria Paula
    Lanchote, Vera Lucia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (02) : 195 - 201
  • [43] The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice
    Landmark, Cecilie Johannessen
    Svendsen, Torleiv
    Dinarevic, Jasmin
    Kufaas, Ruben F.
    Reimers, Arne
    Brodtkorb, Eylert
    Baftiu, Arton
    Burns, Margrete L.
    Guptill, Jeffrey
    Johannessen, Svein I.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 499 - 505
  • [44] THE IMPACT OF PHARMACOKINETIC INTERACTIONS WITH ESLICARBAZEPINE ACETATE VERSUS OXCARBAZEPINE AND CARBAMAZEPINE IN CLINICAL PRACTICE
    Svendsen, T.
    Landmark, Johannessen C.
    Brodtkorb, E.
    Reimers, A.
    Baftiu, A.
    Burns, M. L.
    Johannessen, S., I
    EPILEPSIA, 2016, 57 : 171 - 172
  • [45] Effect of moderate liver impairment on the eslicarbazepine acetate pharmacokinetics
    Almeida, Luis
    Maia, J.
    Potgieter, J. H.
    Soares-da-Silva, P.
    EPILEPSIA, 2007, 48 : 339 - 339
  • [46] Pharmacokinetics of eslicarbazepine acetate in patients with renal impairment.
    Almeida, Luis
    Potgieter, J. Henk
    Maia, Joana
    Soares-da-Silva, P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1193 - 1193
  • [47] Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
    Luis Almeida
    J. Hendrick Potgieter
    Joana Maia
    M. Alida Potgieter
    Fernando Mota
    P. Soares-da-Silva
    European Journal of Clinical Pharmacology, 2008, 64 : 267 - 273
  • [48] DOSAGE FORM PROPORTIONALITY AND FOOD-EFFECT OF THE FINAL TABLET FORMULATION OF ESLICARBAZEPINE ACETATE IN HEALTHY VOLUNTEERS
    Fontes-Ribeiro, C.
    Macedo, T.
    Nunes, T.
    Neta, C.
    Vasconcelos, T.
    Cerdeira, R.
    Lima, R.
    Rocha, J.
    Falcatildeo, A.
    Almeida, L.
    Soares-da-Silva, P.
    EPILEPSIA, 2009, 50 : 109 - 109
  • [49] Eslicarbazepine acetate, an alternative for patients with trigeminal neuralgia with hyponatremia induced by carbamazepine or oxcarbazepine
    Montero, Antonio Alcantara
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (11) : 5430 - 5431
  • [50] Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
    Almeida, Luis
    Potgieter, J. Hendrick
    Maia, Joana
    Potgieter, M. Alida
    Mota, Fernando
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (03) : 267 - 273
12345